Category

ID Perspective

ID Perspective offers commentary and analysis on equine infectious disease from clinicians and researchers working in the field, providing context on emerging pathogens, surveillance findings, and evolving prevention practice.

4 Articles

Coverage here complements case-based reporting with a wider view: what surveillance data is showing, how recommendations are shifting, and what those changes mean for practitioners advising clients on risk.

Frequently Asked Questions About Equine Infectious Disease Perspective

What does ID Perspective cover?

It provides expert commentary on equine infectious disease, including emerging and re-emerging pathogens, surveillance findings, diagnostic developments, vaccination strategy, and changes in prevention and biosecurity guidance.

Why does infectious disease surveillance matter to practitioners?

Surveillance indicates which pathogens are circulating regionally and seasonally, informing vaccination timing, diagnostic suspicion, and the advice given to clients who travel or compete.

How do infectious disease recommendations change over time?

Recommendations evolve as new diagnostic methods, vaccine products, and outbreak data become available. Guidance from bodies such as the AAEP is periodically revised, and practitioners should work from current versions rather than long-held practice.

What is antimicrobial stewardship in equine practice?

Stewardship means using antimicrobials only when indicated, selecting the narrowest effective agent, dosing correctly, limiting duration appropriately, and reserving critically important antimicrobials. It aims to preserve efficacy and slow resistance.

Which emerging threats are practitioners watching?

Attention has focused on vector-borne diseases with shifting geographic ranges, neurologic herpesvirus, novel viral causes of hepatitis and colitis, and resistant bacterial infections in hospitalized patients.

How should practitioners advise clients on travel risk?

Risk advice generally covers vaccination status appropriate to the destination and event, fever monitoring before and after travel, avoiding shared equipment and water sources, minimizing nose-to-nose contact, and a plan for isolation on return if signs develop.